UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.

Kuusk, T; Cullen, D; Neves, JB; Campain, N; Barod, R; Boleti, E; El-Sheihk, S; ... Bex, A; + view all (2021) Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer. BJU International 10.1111/bju.15441. (In press).

[thumbnail of bju.15441.pdf] Text
bju.15441.pdf - Accepted version
Access restricted to UCL open access staff until 9 May 2022.

Download (1MB)

Abstract

OBJECTIVES: To analyse the impact of the COVID-19 pandemic on a centralised specialist kidney cancer care pathway. MATERIALS & METHODS: Retrospective analysis of patient and pathway characteristics including prioritisation strategies at the Specialist Centre for Kidney Cancer (SCKC) located at the Royal Free London NHS Foundation Trust (RFH) before and during the surge of COVID-19. RESULTS: On March 18, 2020 all elective surgery was halted at RFH to redeploy resources and staff for the COVID-19 surge. Prioritising of patients according to European Association of Urology guidance was introduced. Clinics and the specialist multidisciplinary team meetings (SMDT) were maintained with physical distancing, kidney surgery moved to a COVID-protected site and infection prevention measurements were enforced. During the 7 weeks of lockdown (March 23 to May 10, 2020), 234 cases were discussed at the SMDT, 53% compared to 446 in the 7 weeks pre-lockdown. The reduction in referral was more pronounced for small and asymptomatic renal masses. Of 62 low priority cancer patients, 27 (43.5%) were deferred. Only 1 (4%) COVID-19 infection occurred postoperatively followed by full recovery. No increase in clinical or pathological upstaging could be detected in patients who underwent deferred surgery compared to pre-COVID practice. CONCLUSION: The first surge of the COVID-19 pandemic severely impacted diagnosis, referral and treatment of kidney cancer at a tertiary referral centre. With a policy of prioritisation and COVID-protected pathways, capacity for time-sensitive oncological interventions was maintained and no immediate clinical harm was observed.

Type: Article
Title: Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.
Location: England
DOI: 10.1111/bju.15441
Publisher version: https://doi.org/10.1111/bju.15441
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Covid-19, centralisation of care, prioritisation, renal cell carcinoma
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Surgical Biotechnology
URI: https://discovery.ucl.ac.uk/id/eprint/10128131
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item